Arthritis, episcleritis, aphthous stomatitis, ankylosing spondylitis, sacroiliitis, uveitis, sclerotic cholangitis, and skin lesions, which include erythema nodosum and pyoderma gangrenosum, are also frequent manifestations of these associated immune-mediated diseases (5).
However, the new plaster can help in the treatment of mucosal conditions such as oral lichen planus (OLP) -- an inflammatory condition which affects mucous membranes inside the mouth and causes painful lesions-and recurrent aphthous stomatitis (RAS), a condition of shallow sores inside the mouth.
The novel plaster is a breakthrough therapy for the treatment of mucosal conditions such as oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS), which are diseases that cause painful lesions and affect 1-2 percent of the population.
The researchers believe the novel plaster could be a breakthrough therapy for mucosal conditions, such as oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS), both of which cause painful lesions and affect around 1-2% of the population.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.